Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D I Quinn

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|March 7, 2001
The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsD I Quinn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2014
Carboplatin's fourth decade: still searching for its sweet spotD I Quinn
The Medical Journal of Australia|December 16, 1998
Dissecting the rugby tackle: do shoulder pads contribute to cervical spine injuries?D I Quinn
The Medical Journal of Australia|September 16, 1996
Tinea of the skin, hair and nailsD I Quinn
Drug Safety|June 1, 1995
Drug interactions of clinical importance. An updated guideD I Quinn, R O Day
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2013
Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: 'plus or minus' may be a minusT B Dorff, D I Quinn
Clinical Pharmacokinetics|December 10, 1997
Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug usersD I Quinn, A Wodak, R O Day
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2013
Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shoreA Goldkorn, A M Aparicio, D I Quinn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directionsM B Atkins, J I Clark, D I Quinn
The Medical Journal of Australia|August 7, 1995
Non-steroidal anti-inflammatory drugsA G Johnson, D I Quinn, R O Day
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|March 7, 2001
The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsD I Quinn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2014
Carboplatin's fourth decade: still searching for its sweet spotD I Quinn
The Medical Journal of Australia|December 16, 1998
Dissecting the rugby tackle: do shoulder pads contribute to cervical spine injuries?D I Quinn
The Medical Journal of Australia|September 16, 1996
Tinea of the skin, hair and nailsD I Quinn
Drug Safety|June 1, 1995
Drug interactions of clinical importance. An updated guideD I Quinn, R O Day
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2013
Speeding dating for docetaxel and recent debutantes in castration-resistant prostate cancer: 'plus or minus' may be a minusT B Dorff, D I Quinn
Clinical Pharmacokinetics|December 10, 1997
Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug usersD I Quinn, A Wodak, R O Day
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2013
Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shoreA Goldkorn, A M Aparicio, D I Quinn
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directionsM B Atkins, J I Clark, D I Quinn
The Medical Journal of Australia|August 7, 1995
Non-steroidal anti-inflammatory drugsA G Johnson, D I Quinn, R O Day
Pageof 4